Illumina DNA Sequencing Patent Nixed In AIA Review
The Patent Trial and Appeal Board on Tuesday invalidated an Illumina Cambridge Ltd. patent on DNA sequencing that the company alleged is infringed by Intelligent Bio-Systems Inc., the latest decision in...To view the full article, register now.
Already a subscriber? Click here to view full article